Home/Filings/4/0001127602-25-013965
4//SEC Filing

Guerrero Ramiro 4

Accession 0001127602-25-013965

CIK 0001878313other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:14 PM ET

Size

6.9 KB

Accession

0001127602-25-013965

Insider Transaction Report

Form 4
Period: 2025-05-08
Transactions
  • Purchase

    Common Stock

    2025-05-08$1.50/sh+20,000$30,000588,218 total
  • Purchase

    Warrants

    2025-05-08$2.05/sh+20,000$41,00020,000 total
    Exercise: $2.05From: 2026-05-08Exp: 2031-05-08Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on May 8, 2025.
  • [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on May 8, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913253

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:14 PM ET
Size
6.9 KB